DK1727555T3 - Fremstilling af humleekstrakter med östrogen og antiproliferativ bioaktivitet - Google Patents

Fremstilling af humleekstrakter med östrogen og antiproliferativ bioaktivitet

Info

Publication number
DK1727555T3
DK1727555T3 DK04802152T DK04802152T DK1727555T3 DK 1727555 T3 DK1727555 T3 DK 1727555T3 DK 04802152 T DK04802152 T DK 04802152T DK 04802152 T DK04802152 T DK 04802152T DK 1727555 T3 DK1727555 T3 DK 1727555T3
Authority
DK
Denmark
Prior art keywords
estrogen
preparation
hop extracts
antiproliferative
bioactivity
Prior art date
Application number
DK04802152T
Other languages
Danish (da)
English (en)
Inventor
Francis Maes
Keukeleire Denis De
Arne Heyerick
Original Assignee
Metagenics Belgium Bvba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metagenics Belgium Bvba filed Critical Metagenics Belgium Bvba
Application granted granted Critical
Publication of DK1727555T3 publication Critical patent/DK1727555T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Plant Substances (AREA)
DK04802152T 2003-12-16 2004-12-15 Fremstilling af humleekstrakter med östrogen og antiproliferativ bioaktivitet DK1727555T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03447290A EP1543834A1 (en) 2003-12-16 2003-12-16 Production of hop extracts having oestrogenic and antiproliferative bioactivity
PCT/BE2004/000176 WO2005058336A1 (en) 2003-12-16 2004-12-15 Production of hop extracts having oestrogenic and antiproliferative bioactivity

Publications (1)

Publication Number Publication Date
DK1727555T3 true DK1727555T3 (da) 2009-08-17

Family

ID=34486584

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04802152T DK1727555T3 (da) 2003-12-16 2004-12-15 Fremstilling af humleekstrakter med östrogen og antiproliferativ bioaktivitet

Country Status (18)

Country Link
US (2) US20070110835A1 (ru)
EP (2) EP1543834A1 (ru)
JP (2) JP5606660B2 (ru)
CN (1) CN1893963B (ru)
AT (1) ATE429924T1 (ru)
AU (1) AU2004298294B2 (ru)
CA (1) CA2549662C (ru)
DE (1) DE602004020930D1 (ru)
DK (1) DK1727555T3 (ru)
ES (1) ES2326375T3 (ru)
MX (1) MXPA06006782A (ru)
NZ (1) NZ548296A (ru)
PL (1) PL1727555T3 (ru)
PT (1) PT1727555E (ru)
RU (1) RU2370273C2 (ru)
UA (1) UA86607C2 (ru)
WO (1) WO2005058336A1 (ru)
ZA (1) ZA200605478B (ru)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0825506B1 (en) 1996-08-20 2013-03-06 Invensys Systems, Inc. Methods and apparatus for remote process control
US7089530B1 (en) 1999-05-17 2006-08-08 Invensys Systems, Inc. Process control configuration system with connection validation and configuration
WO2000070531A2 (en) 1999-05-17 2000-11-23 The Foxboro Company Methods and apparatus for control configuration
US6788980B1 (en) 1999-06-11 2004-09-07 Invensys Systems, Inc. Methods and apparatus for control using control devices that provide a virtual machine environment and that communicate via an IP network
US8206753B2 (en) 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US7901713B2 (en) 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US8168234B2 (en) 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US8142819B2 (en) 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US7901714B2 (en) 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
MXPA05004288A (es) 2002-10-21 2005-08-02 Metaproteomics Llc Composiciones para tratar o inhibir los estados patologicos asociados con la respuesta inflamatoria.
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
EP1817941A4 (en) * 2004-11-13 2009-11-11 Metaproteomics Llc COMPOSITIONS HAVING INHIBITION OF CYCLO-OXYGENASE-2
DE102005013258B3 (de) * 2005-03-22 2006-10-12 Hopsteiner-Hallertauer Hopfenveredelungsgesellschaft M.B.H. Verfahren zur Herstellung von Naringeninderivaten aus Xanthohumol
AU2012204133B2 (en) * 2005-08-09 2013-09-19 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
EP2248532A1 (en) 2005-08-09 2010-11-10 Metaproteomics, LLP Protein kinase modulation by hops and acacia products cross-reference to related applications
WO2007053915A2 (en) * 2005-11-09 2007-05-18 Universiteit Gent Naringenin derivatives with selectivity on ers
DE102006018988B3 (de) * 2006-04-25 2007-08-09 Nateco2 Gmbh & Co. Kg Verfahren zur Herstellung eines Xanthohumol-haltigen Pulvers hoher Reinheit und dessen Verwendung
EP1958628A1 (en) * 2007-02-16 2008-08-20 KAIROSmed GmbH Combination of immediately liberated drospirenone with a modified releasing formulation containing 8-prenylnaringenin for use in oral contraception and hormone replacement therapy
ATE523202T1 (de) * 2006-11-13 2011-09-15 Nookandeh Baumgaertner Aslieh Dr Extraktionsverfahren zur klassifizierten gewinnung und trennung von pflanzlichen inhaltsstoffen und deren verwendung
CN101677618B (zh) * 2006-12-07 2015-05-13 英博有限公司 废酒花产品、其茋类成分及其在食品工业中作为抗氧化剂的应用
DE102006062264A1 (de) 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen
US8241674B2 (en) 2007-05-11 2012-08-14 Metaproteomics, Llc Methods and compositions for heavy metal detoxification
US7833552B2 (en) 2007-08-15 2010-11-16 Flaxan Gmbh & Co. Kg Xanthohumol-enriched hop extract
US8142821B2 (en) 2007-08-15 2012-03-27 Flazan GmbH & Co. KG Xanthohumol-enriched hop extract
CN101574398B (zh) * 2008-05-09 2011-04-27 上海信谊百路达药业有限公司 啤酒花提取物及其制备方法与应用
CN104407518B (zh) 2008-06-20 2017-05-31 因文西斯系统公司 对用于过程控制的实际和仿真设施进行交互的系统和方法
FR2940089B1 (fr) * 2008-12-24 2011-03-18 Greenpharma Sas Procede de preparation d'un produit enrichi en flavonoides a partir d'un materiel vegetal
US8463964B2 (en) 2009-05-29 2013-06-11 Invensys Systems, Inc. Methods and apparatus for control configuration with enhanced change-tracking
US8127060B2 (en) 2009-05-29 2012-02-28 Invensys Systems, Inc Methods and apparatus for control configuration with control objects that are fieldbus protocol-aware
EP2392325A1 (en) 2010-06-04 2011-12-07 Universitätsklinikum Münster Compounds for the prevention and/or treatment of osteoarthrosis
CN102115772B (zh) * 2010-12-16 2012-11-14 浙江大学 微生物细胞催化异黄腐酚合成8-异戊烯基柚皮素的方法
CN102911033A (zh) * 2011-08-02 2013-02-06 苏州宝泽堂医药科技有限公司 一种从啤酒花中制备黄腐酚的方法
EP2741758B1 (en) 2011-08-08 2016-04-20 Uniwersytet Medyczny W Lodzi Polyphenolic formulation, its preparation and use
CN103371989A (zh) * 2012-04-24 2013-10-30 华东师范大学 黄腐酚在制备抑制破骨细胞分化和蚀骨功能的预防和/或治疗药物中的应用
WO2014025989A1 (en) * 2012-08-10 2014-02-13 Eric Hauser Kuhrts Compositions and methods for treating mood disorders or skin disease or damage
CN103254054B (zh) * 2013-05-08 2015-03-04 浙江大学 一种具有癌症预防作用的化合物及其制备方法
PL223580B1 (pl) 2013-10-04 2016-10-31 Bioactive Tech Spółka Z Ograniczoną Odpowiedzialnością Sposób otrzymywania ksantohumolu o wysokiej czystości
DE102013017165A1 (de) * 2013-10-16 2015-04-16 Eberhard Karls Universität Tübingen Medizinische Fakultät Zusammensetzung zur Immunmodulation
CZ307451B6 (cs) * 2014-12-16 2018-09-05 Vysoká škola chemicko-technologická v Praze Způsob přípravy chmelového materiálu se zvýšeným obsahem 8-prenylnaringeninu a chmelový materiál
JP2018519342A (ja) 2015-07-02 2018-07-19 フラクサン ゲーエムベーハー ウント コー． カーゲー ホップに基づく物質およびその物質の使用
CN107337661A (zh) * 2016-11-30 2017-11-10 南昌大学 一种从啤酒花中提取8‑异戊二烯基‑4,5,7‑三羟黄烷酮的方法
US10758579B2 (en) 2016-12-07 2020-09-01 Metagreen Ventures Systems and methods for extraction of natural products
PL242648B1 (pl) * 2017-06-30 2023-04-03 Bioactive Tech Spolka Z Ograniczona Odpowiedzialnoscia Sposób otrzymywania ksantohumolu
US11291624B2 (en) 2018-07-30 2022-04-05 Conopco, Inc. Compositions comprising active botanical ingredients
US20210401918A1 (en) * 2018-11-23 2021-12-30 Naturetech Co. Ltd. Composition comprising combination of red clover extract and hops extract for improvement of menopausal disorder
WO2021089840A1 (en) 2019-11-08 2021-05-14 Mrm Health N.V. Fermentation method for the production of phytoestrogens
KR20240045217A (ko) * 2021-07-09 2024-04-05 이녹스 코포레이션 암을 치료하는 데 사용하기 위한 프레닐화 칼콘 및 플라보노이드 조성물
CN115650942B (zh) * 2022-10-25 2024-06-04 长沙市惠瑞生物科技有限公司 从啤酒花中提取分离纯化8-异戊烯基柚皮素的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3607298A (en) * 1967-04-11 1971-09-21 Bush Boake Allen Ltd Hop concentrates
GB1274678A (en) * 1968-11-19 1972-05-17 Bush Boake Allen Ltd Hop extracts
GB1246425A (en) * 1970-03-02 1971-09-15 Pfizer Preparation of hop extract
US3839588A (en) * 1971-07-12 1974-10-01 Commw Scient Ind Res Org Process of preparing hop extracts
GB1423129A (en) * 1971-08-04 1976-01-28 Bush Boake Allen Ltd Isomerised hop extracts
DE2613593A1 (de) * 1975-04-02 1976-10-21 Dev Tech Centre Rech Verfahren zur behandlung von hopfen
DD290661A5 (de) * 1989-12-22 1991-06-06 Veb Wtoez Der Brau- Und Malzindustrie,De Verfahren zur herstellung von vorisomerisiertem hopfenextrakt
ATE170919T1 (de) * 1992-06-04 1998-09-15 Steiner Inc S S Herstellung von isomerisiertem hopfenextrakt
JPH09301915A (ja) * 1996-05-08 1997-11-25 Sankyo Co Ltd フラボン及びナフタレン誘導体
JP4374123B2 (ja) * 2000-08-08 2009-12-02 アサマ化成株式会社 食品用防腐剤および食品の防腐方法
AU770436B2 (en) * 2000-09-22 2004-02-19 Unilever Plc Use of prenylated flavones
GB0027769D0 (en) * 2000-11-14 2000-12-27 Unilever Plc Cosmetic method of treating skin
FR2823672B1 (fr) * 2001-04-23 2004-03-12 Berkem Sa Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
DE10139479A1 (de) * 2001-08-10 2003-02-27 Schwabe Willmar Gmbh & Co Hopfenextrakte, Verfahren zu ihrer Herstellung und Verwendung
US7144590B2 (en) * 2003-01-09 2006-12-05 Lipoprotein Technologies, Inc. Bioactive compositions derived from humulus lupulus

Also Published As

Publication number Publication date
CN1893963A (zh) 2007-01-10
RU2370273C2 (ru) 2009-10-20
NZ548296A (en) 2009-09-25
EP1727555B1 (en) 2009-04-29
ES2326375T3 (es) 2009-10-08
ZA200605478B (en) 2009-05-27
CN1893963B (zh) 2010-09-29
JP2012254085A (ja) 2012-12-27
EP1543834A1 (en) 2005-06-22
CA2549662C (en) 2014-02-11
DE602004020930D1 (de) 2009-06-10
RU2006125437A (ru) 2008-01-27
US20110130447A1 (en) 2011-06-02
AU2004298294B2 (en) 2011-05-26
ATE429924T1 (de) 2009-05-15
WO2005058336A1 (en) 2005-06-30
PT1727555E (pt) 2009-08-05
CA2549662A1 (en) 2005-06-30
PL1727555T3 (pl) 2009-10-30
AU2004298294A1 (en) 2005-06-30
JP2007513982A (ja) 2007-05-31
EP1727555A1 (en) 2006-12-06
US20070110835A1 (en) 2007-05-17
UA86607C2 (ru) 2009-05-12
JP5606660B2 (ja) 2014-10-15
MXPA06006782A (es) 2007-01-26

Similar Documents

Publication Publication Date Title
DK1727555T3 (da) Fremstilling af humleekstrakter med östrogen og antiproliferativ bioaktivitet
HK1096608A1 (en) Natural extract containing xanthohumol, and method for the production thereof and products produced therefrom
ATE307126T1 (de) Extraktion von flavonoiden
ITMI20020632A1 (it) Processo per la preparazione di estratti di pomodoro ad elevato contenuto di licopene
ATE327762T1 (de) Effiziente methode zur herstellung von zusammensetzungen, die mit anthocyaninen angereichert sind
ZA200501528B (en) Method for producing avocado leaves extract rich in furan lipids
EP1405858A8 (en) Process for producing sugar chain asparagine derivative
WO2002046749A3 (en) Screening method for identifying compounds that selectively induce interferon alpha
ES2147660T3 (es) Extracto vegetal proteinico y material proteinico enriquecido en isoflavona agluconica, y materiales con alto contenido en genisteina y daidceina y proceso para la produccion de los mismos.
ZA200703874B (en) Process for producing natural immunobiotic extract and uses thereof
DE60236294D1 (de) Neue 2h-pyridazin-3-on derivate, pharmazeutische zusammensetzungen davon sowie ein verfahren zur herstellung derselben
IL203070A (en) Preparations containing extracts of sanguinaria or macaia, and Aquinum Martilus and / or Vitis Winifera and Zanthoxylum Bangum, and their uses
MXPA03008630A (es) Derivados de arilisoxazolinas, procedimientos para su preparacion y su utilizacion como agentes plaguicidas.
PL371319A1 (en) Coumarin derivatives, process for their production and use thereof
IL166386A0 (en) Method for enhancing the nutritive value of plant extract
DK1539798T3 (da) Fremgangsmåde til proteinekstraktion
WO2006099914A8 (de) Verfahren zur herstellung von naringeninderivaten aus xanthohumol
WO2005054222A3 (de) Flavonoid-derivat
ZA200407361B (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof.
AU2003288051A8 (en) Formulations comprising vitamin b12, method of production and use thereof
UA87114C2 (ru) Способ получения экстракта из листьев плюща, экстракт, его применение и лекарственное средство
DE602004013762D1 (de) Basidiomyzeten, basidiomyzetenextraktzusammensetzung sowie reformkost und immunopotentiatoren
DK1228704T3 (da) Fremgangsmåde og udstyr til fremstilling af smagsgivende sammensætninger
DE602004012104D1 (de) Pflanzenextraktionsverfahren und extrakt
AU2003292804A1 (en) Method for producing meat extract